Scarica l'app Stockscreener
86.16
0.57%
0.49
Dopo l'orario di chiusura:
86.77
0.61
+0.71%
Precedente Chiudi:
$85.67
Aprire:
$85.45
Volume 24 ore:
193.68K
Relative Volume:
2.97
Capitalizzazione di mercato:
$531.60M
Reddito:
-
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-37.46
EPS:
-2.3
Flusso di cassa netto:
$-6.82M
1 W Prestazione:
+5.63%
1M Prestazione:
+5.50%
6M Prestazione:
+106.03%
1 anno Prestazione:
+491.35%
Intervallo 1D:
$83.26
$88.86
Intervallo di 1 settimana:
$77.00
$89.86
Portata 52W:
$13.94
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Nome
Monopar Therapeutics Inc
Settore
Industria
Telefono
(847) 388-0349
Indirizzo
1000 SKOKIE BLVD SUITE 350, WILMETTE
Confronta MNPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
86.16 | 528.58M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-09-09 | Iniziato | BTIG Research | Buy |
| 2025-09-03 | Iniziato | Oppenheimer | Outperform |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-08-26 | Ripresa | H.C. Wainwright | Buy |
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-19 | Ripresa | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Piper Sandler | Overweight |
| 2024-10-11 | Iniziato | Rodman & Renshaw | Buy |
| 2021-01-28 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie
Monopar Therapeutics Inc. stock prediction for this weekJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Is Monopar Therapeutics Inc. stock attractive for retirement portfoliosJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Will Monopar Therapeutics Inc. stock deliver long term returns2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com
Why Monopar Therapeutics Inc. stock attracts global investorsEntry Point & Daily Oversold Bounce Ideas - newser.com
Top chart patterns to watch in Monopar Therapeutics Inc.Swing Trade & Accurate Intraday Trading Signals - newser.com
Is Monopar Therapeutics Inc. stock entering bullish territoryPortfolio Return Report & Growth-Oriented Investment Plans - newser.com
Exit strategy if you’re trapped in Monopar Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Has Monopar Therapeutics Inc. formed a bullish divergenceJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Heatmap analysis for Monopar Therapeutics Inc. and competitorsJuly 2025 Decliners & Verified Swing Trading Watchlists - newser.com
When is the best time to exit Monopar Therapeutics Inc.Weekly Loss Report & High Return Stock Watch Alerts - newser.com
Applying sector rotation models to Monopar Therapeutics Inc.Watch List & Verified Technical Trade Signals - newser.com
Monopar Therapeutics’ Innovative Imaging Agent Study: Market Implications - TipRanks
Is Monopar Therapeutics Inc. forming a reversal patternJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
Monopar Therapeutics (MNPR) Price Target Increased by 14.64% to 113.81 - Nasdaq
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingProduct Launch & Advanced Technical Signal Analysis - newser.com
Aug Closing: How Monopar Therapeutics Inc. (1IY0) stock benefits from digital adoptionJuly 2025 Action & Entry Point Confirmation Alerts - fcp.pa.gov.br
Is Monopar Therapeutics Inc. stock attractive for income investorsJuly 2025 Trends & Growth Focused Stock Pick Reports - fcp.pa.gov.br
Why Monopar Therapeutics Inc. stock remains a top recommendationInsider Selling & Weekly Chart Analysis and Guides - newser.com
EV Market: What catalysts could drive Monopar Therapeutics Inc. stock higherQuarterly Market Review & Comprehensive Market Scan Insights - Fundação Cultural do Pará
Monopar Therapeutics Advances Cancer Treatment with New Dose-Escalation Study - TipRanks
Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):